ETF Components for IBRN - iShares Neuroscience and Healthcare ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
PTCT C -2.83 4.40
DYN D -3.23 4.19
BHVN C -2.80 4.14
ALKS C 3.00 4.02
ITCI D -0.71 3.99
CPRX C 1.71 3.97
XENE F 2.57 3.95
ACAD F -0.52 3.89
AXNX A -0.27 3.80
BIIB F -1.57 3.76
NBIX F -0.93 3.73
SRPT F -2.05 3.73
SUPN D 2.63 3.13
EWTX B 2.32 3.08
SAVA D -6.83 2.35
AVDL F 0.34 2.26
LBPH D 11.28 2.12
IART F -3.69 2.11
PRAX C -0.19 1.88
PRTA F -0.48 1.87
SRRK F -6.99 1.14
ANNX C 3.21 1.10
AXGN B 2.07 1.09
DNTH D 1.83 1.05
AVXL D -4.23 0.86
ELYM F 1.38 0.81
ALEC F -2.36 0.81
NGNE C -7.48 0.78
RAPP D -0.83 0.71
TSHA F 0.50 0.63
ZVRA D -1.30 0.59
TRDA D 0.13 0.59
ANRO D -2.36 0.57
CLPT C -3.57 0.55
VYGR F 0.00 0.53
CTNM D -2.30 0.52
LRMR F -4.27 0.49
SLDB F -2.73 0.48
VNDA F -3.20 0.47
ABEO C 2.22 0.44
PEPG F 3.98 0.44
NVRO F -6.44 0.38
SGMO D -4.87 0.36
CAPR C -1.31 0.28
AMLX D -5.56 0.24
ABOS F -1.21 0.21
HKD D -5.33 0.00

Recent News for iShares Neuroscience and Healthcare ETF & its Holdings

Date Stock Title
Oct 1 NVRO Breaking Down Nevro: 10 Analysts Share Their Views
Oct 1 DNTH Dianthus Therapeutics files $500M mixed shelf offering
Oct 1 LBPH Longboard Pharmaceuticals gains amid takeover speculation
Oct 1 SRPT Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Oct 1 PEPG Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Oct 1 CAPR Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Oct 1 CPRX Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?
Oct 1 PTCT PTC Therapeutics brain disorder therapy granted FDA review
Oct 1 PTCT PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients
Oct 1 CPRX Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
Oct 1 EWTX Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
Oct 1 BHVN Biohaven prices $250M share offering
Oct 1 BHVN Biohaven Announces Pricing of $250 Million Public Offering of Common Shares
Oct 1 PTCT 5 FDA decisions to watch in the fourth quarter
Oct 1 BHVN Acuity Brands, Nike And 3 Stocks To Watch Heading Into Tuesday
Sep 30 NBIX Neurocrine touts long-term effectiveness of Ingrezza for Huntington's disease chorea
Sep 30 BHVN Biohaven proposed public offering of common shares
Sep 30 ABOS Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
Sep 30 PRTA Dow Dips 300 Points; Emcore Shares Spike Higher
Sep 30 SRPT Is Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to Buy According to Analysts?
iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.
Exchange Traded Funds Biopharmaceutical Ishares Blackrock Neuroscience
Back to the Main IBRN Page...